CompaniesByCap
INFU
InfuSystem Holdings Inc. (INFU)
NYSE · Healthcare

InfuSystem Holdings Inc. Revenue 2009–2025

InfuSystem Holdings Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • InfuSystem Holdings Inc. revenue for the quarter ending March 31, 2026 was 33.7 M, a 2.97% decrease year-over-year.
  • InfuSystem Holdings Inc. revenue for the twelve months ending March 31, 2026 was 140.9 M, a 5.99% increase year-over-year.
  • InfuSystem Holdings Inc. annual revenue for 2025 was 143.4 M, a 6.36% increase from 2024.
  • InfuSystem Holdings Inc. annual revenue for 2024 was 134.9 M, a 7.22% increase from 2023.
  • InfuSystem Holdings Inc. annual revenue for 2023 was 125.8 M, a 14.44% increase from 2022.
  • InfuSystem Holdings Inc. annual revenue for 2022 was 109.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

InfuSystem Holdings Inc. (INFU) — Frequently Asked Questions

InfuSystem Holdings Inc. (INFU) is a publicly traded US company. It has a market capitalization of $191M. In fiscal 2025 it reported revenue of $143M and net income of $7M. Explore INFU's stock price, financial statements, earnings history, margins and key ratios below.

What is InfuSystem Holdings Inc.'s market cap?

InfuSystem Holdings Inc. (INFU) has a market capitalization of $191M.

What is the INFU stock price?

INFU trades at $9.03 (+1.69% on the day).

How much revenue does InfuSystem Holdings Inc. make?

InfuSystem Holdings Inc. reported revenue of $143M in fiscal 2025.

Is INFU profitable?

In fiscal 2025, InfuSystem Holdings Inc. reported net income of $7M.

What is INFU's P/E ratio?

Based on diluted EPS, INFU has a price-to-earnings (P/E) ratio of about 29.1.